Comparative Biosciences Inc., a premier preclinical contract research organization (CRO), is committed to providing expert high-quality contract research services to all sectors of the biomedical community. Extensive experience in the biotechnology and pharmaceutical industries provides our staff with a solid track record in preclinical research and drug development capabilities.
Comparative Biosciences, Inc. (CBI) provides state-of-the-art preclinical contract toxicology, pharmacokinetics, pharmacology, efficacy, and histology/histopathology studies to the biopharmaceutical, academic, veterinary, chemical-agricultural, military-defense, and governmental industries. Toxicology research services include pilot, acute, subacute and chronic GLP, nonGLP, and pharmacokinetic/pharmacodynamic studies in all species including mice, rats, hamsters, guinea pigs, rabbits, dogs, and pigs. We offer a wide range of pharmacology capabilities including ocular, otic, dermal, inflammatory, immune mediated, cardiovascular, xenograft, anti-infection, and metabolic efficacy in vivo and pharmacology modeling. Our contract histopathology laboratory provides comprehensive GLP and research histology and pathology including tissue cross-reactivity studies, special stains, cytocochleograms, immunohistochemistry, plastics, and image analysis.
CBI offers specialization in ophthalmologic contract research services. We provide preclinical research services in the areas of ocular toxicology, pharmacokinetics, and pharmacology/in vivo modeling.
Our new state-of-the-art facilities includes laboratories, vivarium, surgery, tissue culture, histology, ophthalmology, on site ACVP board-certified veterinary pathologists, image analysis, CT scanning, confocal microscopy, clinical pathology, and quality assurance. We are AAALAC accredited, have FDA, USDA, and OLAW registrations, and comply with FDA, OECD, and ICH guidelines.
The mission at Comparative Biosciences Inc. is to provide the same level of excellence to the determined biotech startup that we deliver on a scalable level to the largest pharmaceutical company.
Follow the links on the left to learn more about Comparative Biosciences, Inc., our array of capabilities and services, and our commitment to ongoing excellence in biomedicine.
